Mieke Demeulenaere

Head Of Communications & PR at Multipharma

Mieke Demeulenaere has a diverse work experience spanning over several decades. Mieke is currently the Head of Communications & PR at Multipharma since August 2021. Previously, they founded and owned PeppeRmint PR Brussels in 2009, where they developed and implemented press and influencer campaigns for various clients. Mieke also worked as a Partner at Shepard Fox Communications LLC, managing international media relations campaigns for clients such as the European Patent Office and Bosch. Additionally, they served as an Account Director a.i. at BCW Brussels in early 2021, and as a Senior Director at Grayling from 2018 to 2020, leading accounts for companies like Jaguar Land Rover and Nikon. Prior to that, they worked as a Senior Account Manager at Trimedia Benelux for ten years, overseeing the Healthcare & FMCG PR Department. Mieke also has experience as a Press Officer at Columbia Tristar Fox Films and Era Films in the mid-1990s.

Mieke Demeulenaere completed their education history with a postgraduate degree in Communication from KU Brussels in the year 1996. Before that, they pursued their studies in Germanic languages and obtained a Teacher's degree from Katholieke Universiteit Leuven and Universiteit Leiden between 1990 and 1994. Prior to their higher education, they attended Lyceum Hemelsdaele in Bruges, where they focused on Latin and Mathematics, although the exact start and end years for this period are not provided.

Location

Brussels, Belgium

Links

Previous companies


Org chart


Teams


Offices


Multipharma

As a pioneer in pharmaceutical care, Multipharma wants to strengthen the role of the pharmacist with the aim to make high quality healthcare accessible and affordable to all. To fulfill this mission, Multipharma can lean on its network of 245 pharmacies and the combined competences of 1,800 employees. Multipharma also has a high-tech distribution centre and state-of-the-art specialised pharmacies for the individual packaging of medicines for patients in residential care and other care institutions.